41 related articles for article (PubMed ID: 2790044)
1. Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells.
Pinnaduwage P; Schmitt L; Huang L
Biochim Biophys Acta; 1989 Oct; 985(1):33-7. PubMed ID: 2790044
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Antitumor Activity of Quaternary Ammonium Surfactants.
Hyla K; Jama D; Grzywacz A; Janek T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139066
[TBL] [Abstract][Full Text] [Related]
3. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.
Torchilin VP; Levchenko TS; Rammohan R; Volodina N; Papahadjopoulos-Sternberg B; D'Souza GG
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1972-7. PubMed ID: 12571356
[TBL] [Abstract][Full Text] [Related]
4. Effect of the amount of cationic lipid used to complex siRNA on the cytotoxicity and proinflammatory activity of siRNA-solid lipid nanoparticles.
Hanafy MS; Dao HM; Xu H; Koleng JJ; Sakran W; Cui Z
Int J Pharm X; 2023 Dec; 6():100197. PubMed ID: 37521246
[TBL] [Abstract][Full Text] [Related]
5. Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID-19.
Alavizadeh SH; Doagooyan M; Zahedipour F; Torghabe SY; Baharieh B; Soleymani F; Gheybi F
IET Nanobiotechnol; 2022 May; 16(3):67-77. PubMed ID: 35274474
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional Neomycin-Triazine-Based Cationic Lipids for Gene Delivery with Antibacterial Properties.
Pennetta C; Bono N; Ponti F; Bellucci MC; Viani F; Candiani G; Volonterio A
Bioconjug Chem; 2021 Apr; 32(4):690-701. PubMed ID: 33470802
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in siRNA delivery mediated by lipid-based nanoparticles.
Yonezawa S; Koide H; Asai T
Adv Drug Deliv Rev; 2020; 154-155():64-78. PubMed ID: 32768564
[TBL] [Abstract][Full Text] [Related]
8. Non-viral transfection vectors: are hybrid materials the way forward?
Gigante A; Li M; Junghänel S; Hirschhäuser C; Knauer S; Schmuck C
Medchemcomm; 2019 Oct; 10(10):1692-1718. PubMed ID: 32180915
[TBL] [Abstract][Full Text] [Related]
9. Transfection by cationic gemini lipids and surfactants.
Damen M; Groenen AJJ; van Dongen SFM; Nolte RJM; Scholte BJ; Feiters MC
Medchemcomm; 2018 Sep; 9(9):1404-1425. PubMed ID: 30288217
[TBL] [Abstract][Full Text] [Related]
10. trans-Double Bond-Containing Liposomes as Potential Carriers for Drug Delivery.
Giacometti G; Marini M; Papadopoulos K; Ferreri C; Chatgilialoglu C
Molecules; 2017 Nov; 22(12):. PubMed ID: 29182583
[TBL] [Abstract][Full Text] [Related]
11. Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.
Campani V; Salzano G; Lusa S; De Rosa G
Nanomaterials (Basel); 2016 Jul; 6(7):. PubMed ID: 28335259
[TBL] [Abstract][Full Text] [Related]
12. Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid Tumors.
Wen Y; Meng WS
J Pharm Innov; 2014 Jun; 9(2):158-173. PubMed ID: 25221632
[TBL] [Abstract][Full Text] [Related]
13. Modulation of pyridinium cationic lipid-DNA complex properties by pyridinium gemini surfactants and its impact on lipoplex transfection properties.
Sharma VD; Lees J; Hoffman NE; Brailoiu E; Madesh M; Wunder SL; Ilies MA
Mol Pharm; 2014 Feb; 11(2):545-59. PubMed ID: 24377350
[TBL] [Abstract][Full Text] [Related]
14. Overcoming nonviral gene delivery barriers: perspective and future.
Jones CH; Chen CK; Ravikrishnan A; Rane S; Pfeifer BA
Mol Pharm; 2013 Nov; 10(11):4082-98. PubMed ID: 24093932
[TBL] [Abstract][Full Text] [Related]
15. Cationic gemini surfactants as new agents for plasmid DNA delivery into cells.
Grigoriev IV; Korobeinikov VA; Cheresiz SV; Pokrovsky AG; Zakharova LY; Voronin MA; Lukashenko SS; Konovalov AI; Zuev YF
Dokl Biochem Biophys; 2012; 445():197-9. PubMed ID: 22941102
[No Abstract] [Full Text] [Related]
16. Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection.
Wang W; Zhou F; Ge L; Liu X; Kong F
Int J Nanomedicine; 2012; 7():2513-22. PubMed ID: 22679364
[TBL] [Abstract][Full Text] [Related]
17. Bioreducible liposomes for gene delivery: from the formulation to the mechanism of action.
Candiani G; Pezzoli D; Ciani L; Chiesa R; Ristori S
PLoS One; 2010 Oct; 5(10):e13430. PubMed ID: 20976172
[TBL] [Abstract][Full Text] [Related]
18. Targeting anticancer drugs to tumor vasculature using cationic liposomes.
Abu Lila AS; Ishida T; Kiwada H
Pharm Res; 2010 Jul; 27(7):1171-83. PubMed ID: 20333455
[TBL] [Abstract][Full Text] [Related]
19. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
20. Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania.
Chakraborty R; Dasgupta D; Adhya S; Basu MK
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):393-6. PubMed ID: 10333480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
